Affluent Medical | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Affluent Medical

BRIEF

published on 11/07/2024 at 17:50, 13 days 16 hours ago

Affluent Medical: Update of Shares and Voting Rights

Euronext Paris Share Capital Voting Rights Affluent Medical Financial Transparency
BRIEF

published on 10/08/2024 at 17:50, 1 month 12 days ago

Affluent Medical to Engage in Key Scientific Conferences

Innovative Technologies Healthcare Solutions Medical Devices Affluent Medical Scientific Conferences
BRIEF

published on 10/08/2024 at 17:50, 1 month 12 days ago

Affluent Medical to Participate in Key Scientific Conferences

Affluent Medical Medical Innovation Scientific Conferences Kalios™, Epygon Artus Sphincter
PRESS RELEASE

published on 10/08/2024 at 17:45, 1 month 12 days ago

Affluent Medical Announces Participation in Upcoming Scientific Events
Affluent Medical announces participation in upcoming scientific events to showcase mitral valve and urinary sphincter technologies. Learn more at the conferences

Medical Technology Affluent Medical Mitral Valve Scientific Events Urinary Sphincter
PRESS RELEASE

published on 10/08/2024 at 17:45, 1 month 12 days ago

Affluent Medical Announces Participation in Upcoming Scientific Events.
Affluent Medical to participate in EACTS 2024, ICS 2024, and PCR London Valves scientific conferences showcasing its innovative medical devices. CEO Ladet looks forward to discussing future partnerships and advancements

Innovation Medical Devices Affluent Medical Partnerships Scientific Conferences
BRIEF

published on 10/07/2024 at 17:50, 1 month 13 days ago

Affluent Medical: Status of shares and voting rights as of September 30, 2024

Euronext Paris Share Capital Voting Rights Actions Affluent Medical
BRIEF

published on 09/26/2024 at 17:50, 1 month 24 days ago

Affluent Medical SA Achieves Major Milestones in H1 2024

Financial Results Epygon Valve Strategic Agreements Kalios™ Artus Pilot Study
PRESS RELEASE

published on 09/26/2024 at 17:45, 1 month 24 days ago

Affluent Medical SA: H1 2024 RESULTS - Major advances in all three programs - Several strategic agreements signed with the world medtech leader in cardiology - Extension of financial runway
Affluent Medical SA reports major advances in all three programs in H1 2024, signs strategic agreements with medtech leader, and extends financial runway. Detailed financial results available on the website

Strategic Agreements H1 2024 Results Affluent Medical SA Medtech Leader Financial Runway
PRESS RELEASE

published on 09/26/2024 at 17:45, 1 month 24 days ago

Affluent Medical : H1 2024 results.
French medical technology company, Affluent Medical, releases H1 2024 results including advances in programs, strategic agreements, and financial extension to July 2025

Medical Devices Affluent Medical Financial Extension Strategic Agreements H1 2024 Results
BRIEF

published on 09/12/2024 at 18:49, 2 months 8 days ago

Affluent Medical presents its operational advances

Medical Devices Funding Partnership Clinical Trials Affluent Medical

1 2 ... 7

Accesswire

Published on 11/21/2024 at 10:03, 45 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 48 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 48 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 13 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 23 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 18 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 43 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 46 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 48 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 48 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 50 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 28 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 3 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 3 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE